Planning

CONTRAST MEDIA INCLUDING INJECTORS AND ASSOCIATED PRODUCTS (SBS 10257)

  • NHS Shared Business Services Limited

F01: Prior information notice (prior information only)

Notice identifier: 2023/S 000-011159

Procurement identifier (OCID): ocds-h6vhtk-03c1db

Published 18 April 2023, 6:27pm



Section one: Contracting authority

one.1) Name and addresses

NHS Shared Business Services Limited

Three Cherry Trees Lane, Hemel Hempstead

Hertfordshire

HP2 7AH

Contact

Adam Connell

Email

nsbs.health@nhs.net

Country

United Kingdom

Region code

UK - United Kingdom

Companies House

05280446

Internet address(es)

Main address

https://www.sbs.nhs.uk/

Buyer's address

https://www.sbs.nhs.uk/

one.3) Communication

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Other type

https://www.sbs.nhs.uk/nhs-sbs-about-us

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

CONTRAST MEDIA INCLUDING INJECTORS AND ASSOCIATED PRODUCTS (SBS 10257)

Reference number

SBS 10257

two.1.2) Main CPV code

  • 33696800 - X-ray contrast media

two.1.3) Type of contract

Supplies

two.1.4) Short description

NHS Shared Business Services Limited (NHS SBS) act in an Agency capacity for and on behalf of its customers (Approved Organisations) - existing and new. These comprise of NHS and Social Care organisations (whether acting individually, or on behalf of, or together as members of any consortia) along with any other public or private sector bodies which NHS SBS authorises to use the resulting Framework.

NHS SBS intends to put in place a Framework Agreement for the provision of Contrast Media including Injectors and Associated Products and related Goods and Services for Healthcare to be used by NHS SBS Approved Organisations.

Our Approved Organisation list can be found at:

https://sbs.nhs.uk/proc-framework-agreements-support

We are committed to working with suppliers who are dedicated to Sustainability and Social Value and there will be a significant weighting on these elements in the tender.

two.1.5) Estimated total value

Value excluding VAT: £70,000,000

two.1.6) Information about lots

This contract is divided into lots: Yes

two.2) Description

two.2.1) Title

Contrast Media

Lot No

1

two.2.2) Additional CPV code(s)

  • 33696800 - X-ray contrast media

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

This lot is for the provision of Contrast Media:

• Ionic iodine based Contrast Media for use in all relevant procedures

• Non Ionic iodine based Contrast Media (including high and Low Osmolarity) for use in all relevant procedures

• Paramagnetic Contrast Media for use in all relevant procedures.

• Specialist Contrast Media Products including but not limited to:-

• Contrast agents for gastro-intestinal examinations including barium sulphate, (includes lower GI tract exam media),

• Oral contrast media for GI tract and CT scans,

• Ultrasound contrast agents,

two.2) Description

two.2.1) Title

Injectors and Associated Products

Lot No

2

two.2.2) Additional CPV code(s)

  • 33696800 - X-ray contrast media

two.2.3) Place of performance

NUTS codes
  • UK - United Kingdom

two.2.4) Description of the procurement

This lot is for the provision of Injectors and Associated Products:

• Injectors (including service and maintenance)

• Ancillaries / Associated Products / Maintenance.

two.3) Estimated date of publication of contract notice

29 August 2023


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section six. Complementary information

six.3) Additional information

This Prior Information Notice (PIN) is to signal an intention to commence market engagement with those within the Contrast Media market.

A Request for Information (RFI) form can be obtained from nsbs.health@nhs.net

Requests to participate must be submitted electronically by way of completing and responding to the RFI via email to nsbs.health@nhs.net by 12 noon Friday the 19th of May 2023.

NHS Shared Business Services Limited (NHS SBS) reserves the right to withdraw this notice at any time. NHS SBS is not bound to accept any proposals submitted by Bidders and is not liable for any costs incurred as a result of Bidders engaging with this process. This early market engagement exercise does not guarantee that a Procurement will take place and NHS SBS reserves the right to defer from any Procurement entirely.

NHS SBS intends to hold market engagement sessions during May and June 2023 with industry experts and suppliers interested in potentially bidding for the resulting Framework Agreement.

Please note that, to register, you must have a valid DUNS number (as provided by Dun and Bradstreet) for the organisation which you are registering, who will be entering into a Framework Agreement if invited to do so.

The value in II.1.5 is an indicative value over 4 years from 9th March 2024.

The date in II.3) is the estimated date of publication, please monitor Find a Tender Service https://www.find-tender.service.gov.uk/Search for the publication of the relevant high value contract notice.